It has been shown that mitochondrial DNA (mtDNA) content is associated with type 2 diabetes (T2D) and related traits. However, empirical data, often based on small samples, did not confirm this observation in all studies. Therefore, the role of mtDNA content in T2D remains elusive.
M
itochondria contribute to multiple cellular processes such as ATP synthesis, ␤-oxidation of fatty acids, and apoptosis. They have their own circular genome, of approximately 16 kb, which exists in multiple copies per mitochondrion. Mitochondrial DNA (mtDNA) encodes for two rRNAs, all mitochondrial tRNAs, and 13 subunits of the respiratory chain. These 13 subunits are synthesized by the mitochondrial protein synthesis machinery inside the mitochondrial matrix. Because the complete pool of mitochondrial proteins consists of approximately 1500 proteins, only a fraction of them is encoded and synthesized inside the mitochondrion. Quantities of mtDNA, the so-called mtDNA content, vary between individuals and tissues within an individual. In muscle, dynamic adaptation is observed in relation to physical exercise (1, 2) . Mutations in the human POLG gene and knockdown of Tfam in mouse models, two of the most important regulators of mtDNA content, result in mtDNA depletion, showing that nuclear factors are involved in the regulation of mtDNA content (3, 4) . Furthermore, it has previously been shown in humans that the mtDNA content in blood cells is partially heritable (5, 6) . In this study, we readdress the heritability of mtDNA content using buccal swabs from mono-and dizygotic twins and their siblings.
Evidence is accumulating that mtDNA content is associated with type 2 diabetes. However, there is debate about whether mitochondrial dysfunction is primary or secondary to type 2 diabetes. HIV-infected patients treated with highly active antiretroviral therapy containing nucleoside analogs show a 30 -50% decreased mtDNA content, redistribution of body fat, insulin resistance, and an increased risk for development of type 2 diabetes, favoring the hypothesis that mitochondrial dysfunction is a cause rather than a consequence of development of type 2 diabetes (7) (8) (9) .
It has been shown that low mtDNA content precedes type 2 diabetes (10). However, in a sample of 141 nondiabetic adult offspring who had one parent with type 2 diabetes, no difference in mtDNA content in blood was observed compared with controls (11) . Other studies showed evidence that mtDNA content is associated with the pattern of triglyceride storage, insulin secretion, insulin sensitivity, and glucose metabolism (12) (13) (14) (15) . Furthermore, mtDNA content is decreased in Goto-Kakizaki rat, which is a genetic model for type 2 diabetes (16) .
Because the association of mtDNA content with type 2 diabetes is not confirmed in all studies, the role of mtDNA content in the onset of type 2 diabetes remains not fully understood. The aim of the current study was to elucidate this important issue. We assessed the heritability of mtDNA content in participants from The Netherlands Twin Register while taking into consideration several lifestyle variables. Next, we assessed the association of mtDNA content with prevalent and incident cases of type 2 diabetes in a Dutch case control study and in selected samples from two prospective studies from Finland and The Netherlands.
Subjects and Methods

Sample selection
Heritability
For estimation of the heritability, participants were recruited from The Netherlands Twin Register (17, 18) . The sample consisted of 391 twins and 12 of their siblings from 212 families as part of a study on depression and anxiety (19) and smoking behavior (20) . DNA was extracted from buccal cells. Assessment of zygosity was based on DNA polymorphisms. There were 183 complete twin pairs [38 monozygotic (MZ) male, 23 dizygotic (DZ) male, 60 MZ female, 45 DZ female, and 17 DZ pairs of opposite sex] and 25 incomplete pairs (five MZ male, three DZ male, 12 MZ female, and five DZ female). The sibling group consisted of five males and seven females.
Information on body mass index (BMI), smoking, and exercise was obtained from longitudinal surveys and from data collected at the time of DNA sampling.
Case control study of prevalent type 2 diabetes
For the case control study, we selected 175 normal glucose tolerant (NGT) Caucasian participants from the Dutch New Hoorn Study (NHS). A total of 154 prevalent type 2 diabetes patients from NHS and the Diabetes Care System West-Friesland (DCS) were matched for age (21) . NHS is a population-based study from the city of Hoorn, The Netherlands, which aims to examine potential determinants for glucose intolerance and related disorders. Glucose tolerance was assessed by oral glucose tolerance test (OGTT) following World Health Organization (WHO) 1999 criteria (22) . DCS aims to improve diabetes care by coordinating the diabetes care involving all caregivers and providing education of patients to improve patient empowerment. Patients are referred to the DCS by their physicians and are from the same geographical region as the NHS. DNA was extracted from whole blood.
Prospective study of incident type 2 diabetes
To prospectively analyze the association between mtDNA content and incident cases of type 2 diabetes, we selected samples from two prospective studies. The first was the Botnia study (designated prospective 1), which aims at the identification of genes increasing susceptibility to type 2 diabetes (23). This family study includes 2770 participants, which were healthy at baseline, originating from the Botnia region in Finland. Glucose tolerance at baseline and after follow-up was tested using OGTT following WHO 1999 criteria (22) . DNA was extracted from whole blood drawn at baseline. DNA from 133 participants who converted to type 2 diabetes (converters) was available. A total of 311 nonconverters were matched based on age and BMI at baseline and on gender. We allowed the inclusion of impaired glucose tolerant (IGT) and impaired fasting glucose (IFG) participants because these covered a large proportion of the converter group. The converter group included 55 NGT, 37 IGT, 20 IFG, and 24 IGTϩIFG participants at baseline. The nonconverter group included 245 NGT, 45 IGT, 26 IFG, and 15 IGTϩIFG participants at baseline. Family history (first-degree relatives) of type 2 diabetes was present in 83.8% of the converter group and 67.2% of the nonconverter group.
The second prospective study was the Dutch Rotterdam study (n ϭ 7983; designated prospective 2), which is a populationbased study aiming to investigate determinants of disease occurrence and progression in the elderly (24) . DNA was extracted from buffy coat, obtained from blood drawn at baseline. Diabetic state at baseline was assessed using a random glucose tolerance test, which was shown to have a good correlation with OGTT (25) . Glucose tolerance after follow-up was assessed using OGTT following WHO 1999 criteria (22) . From this study, 113 converters were available. We matched 125 nonconverters based on age and BMI at baseline and on gender. Entry of IGT participants at baseline was allowed (n ϭ 20 in the converter group and n ϭ 1 in the nonconverter group).
All studies were approved by the appropriate medical ethical committees and were in accordance with the principles of the Declaration of Helsinki. Study samples are summarized in Table 1 .
Measurement of mtDNA content
mtDNA content was assessed using a modification of the quantitative real-time PCR-based method we described previously (26) . In short, the relative amount of mtDNA was quantified by comparison with a nuclear target, which was the betaglobin gene (HBB). A fragment of mtDNA was amplified between nucleotide positions 3780 and 3842, which is located in MT-ND1 on the heavy strand transcript (primer sequences available on request). Quantitative real-time PCR was performed using the Applied Biosystems 7900HT (Applied Biosystems, Foster City, CA). Absolute QPCR SYBR Green ROX mix was used (Thermo Fisher Scientific Inc., Waltham, MA). For quantification, reference curves that were serial dilutions of a standard DNA were used. A ratio between mtDNA and HBB was calculated (mtDNA/HBB), which is here used as the mtDNA content. Each sample was measured at least in triplicate, and mean values were calculated. Specificity of amplification was tested by dissociation curves and water controls. Approximately 50% of samples were repeated and showed a high concordance in all study samples with initial results (r 2 Ն 0.8). mtDNA content is assessed in several tissues (buccal cells, whole blood, and buffy coats). It is known that DNA extraction from these different samples can result in variance in mtDNA content. Therefore, differences in mtDNA content between the independent study samples is observed (27, 28) .
Statistical analysis
Heritability study
Twin studies make use of the genetic relatedness of twins and their family members. MZ twins are genetically identical, whereas DZ twins share on average 50% of their segregating genes, like other siblings (29) . Twin studies compare the correlation of a phenotype, such as mtDNA content, within MZ twin pairs with the resemblance within DZ twin and sibling pairs. If the correlation in MZ twins is about twice as large as the correlation in DZ twins, familial resemblance is explained by additive genetic effects (A). When the DZ correlation is more than half the MZ correlation, there is evidence for environmental effects shared by twins and siblings from the same family (C). Differences within MZ twin pairs are due to unique environmental influences (E), which also include measurement error. The observed variance thus can be decomposed into variance components A, C, and E (30) .
Statistical analyses were performed using structural equation modeling as implemented in the software package Mx (31) . The raw data full information maximum likelihood approach in Mx was used to fit different models to the data (for example, ACE and AE models). Testing of submodels was done by means of likelihood-ratio tests, by subtracting the negative log likelihood (Ϫ2LL) for the more restricted model (e.g. AE) from the Ϫ2LL for the more general model (e.g. ACE). This yields a statistic that is distributed as 2 with degrees of freedom (df) equal to the difference in the number of parameters in the two models. We first fitted a saturated model to the data in which means, variances, and correlations were estimated as well-fixed effects of age, sex, BMI, and physical activity on mtDNA content.
Case control study of prevalent type 2 diabetes
The association of mtDNA content with prevalent type 2 diabetes in the case control study was analyzed with logistic regression with adjustment for age, gender, and BMI. mtDNA content in each cohort was adjusted for age, gender, and BMI with general linear models. Continuous traits were analyzed with linear regression with adjustment for age, BMI, and gender (where appropriate) only in NGT participants. SPSS software (SPSS Inc., Chicago, IL) was used for these statistical analyses.
Prospective study of incident type 2 diabetes
Because the prospective 1 sample (Botnia study) is a familybased study, we adjusted for family relation. To do so, we made use of general estimating equations with logistic regression, which takes into account family relatedness when calculating the SE values. Conversion to type 2 diabetes was adjusted for age, BMI, and glucose tolerance at baseline and gender and family history of diabetes. Estimated average mtDNA content was cal- 
Power calculation
Before the study, power calculations were performed using Lenth's power and sample-size calculator (http://www.stat.uiowa. edu/ϳrlenth/Power/index.html; web site accessed on May 20, 2008) . We assumed a population SD of 30%. For the association with prevalent or incident type 2 diabetes, a sample size of 160 cases and controls is needed for 80% power to detect a difference of at least 10% (␣ ϭ 0.05).
Results
Heritability
Regression of gender, age, exercise, and BMI on mtDNA content indicated that mean mtDNA content was lower in subjects who do not exercise, are women, are older, or have a higher BMI. These four covariates thus explain a significant part (4%) of the variance in mtDNA content. Genetic modeling with these covariates yielded twin correlations of 0. 34 Prevalent type 2 diabetes and mtDNA content mtDNA content was assessed in a case control study ascertained from the Dutch NHS and DCS, originating from the same geographic location. Estimated mean mtDNA content in prevalent cases of type 2 diabetes and controls was 0.30 (0.28 -0.31) and 0.29 (0.28 -0.30), respectively (P ϭ 0.51) ( Table 2) . Also, after logistic regression with adjustment for possible confounders (BMI, age, and gender), we could not detect an effect on type 2 diabetes susceptibility (P ϭ 0.56). Furthermore, we could not find any evidence for a correlation between mtDNA content and other relevant variables (Supplemental Tables 1 and 2 , published as supplemental data on The Endocrine Society's Journals Online web site at http://jcem.endojournals.org).
Incident type 2 diabetes and mtDNA content
mtDNA content was first assessed in the prospective 1 sample. Estimated mean mtDNA content in converters and nonconverters was 0.38 (0.36 -0.40) and 0.40 (0.39 -0.42), respectively (P ϭ 0.08) ( Table 2 ). Using logistic regression with adjustment for possible confounders (age, gender, BMI, glucose tolerance at baseline, and family clustering), we also observed a weak regression toward decreased mtDNA content with increased type 2 diabetes risk, but this did not reach statistical significance (P ϭ 0.10). No associations between mtDNA content and OGTT-derived variables were observed.
Next, mtDNA content was assessed in the prospective 2 sample. Estimated mean mtDNA content in converters and nonconverters was 0.55 (0.50 -0.59) and 0.51 (0.46 -0.56), respectively (P ϭ 0.18) ( Table 2) . Logistic regression with adjustment for possible confounders gave a similar result (P ϭ 0.17).
All studies showed a trend toward decreasing mtDNA content with increasing age (Supplemental Table 1 ). However, for most studies, this did not reach statistical significance. Therefore, we pooled all data to increase power and repeated the analysis. mtDNA content of each independent study was normalized using the average mtDNA content to make the data comparable. To avoid heterogeneity, we excluded the twin data for this analysis because this was the only study for which DNA was extracted from buccal swabs. Using generalized estimating equations with correction for family relatedness and study sample, we observed a statistical significant decrease in mtDNA content with increasing age [B ϭ Ϫ0.003/yr (Ϫ0.005 to Ϫ0.0007); P ϭ 0.009]. Correction for BMI did not influence the data. However, the association seems to Table 2 ). The pooled sample was not corrected for exercise because assessment of exercise was performed with different questionnaires.
Discussion
Heritability
In this study, we showed that mtDNA content has a heritability of 35% (95% CI, 19 -48%) in buccal cells. This partially confirms results from other groups who analyzed mtDNA content in blood and reported heritability between 33 and 65% (5, 6) . However, the reported heritability of 65% is higher than our finding. This might be caused by a different ethnicity of participants or different types of tissue used.
In our study, mtDNA content in buccal cells is not affected by smoking behavior, so this could not bias our results. However, two other studies did show modest effects of smoking on mtDNA content in buccal cells and whole blood (6, 32) .
Prevalent type 2 diabetes and mtDNA content
Inconsistency in literature is observed concerning the association of mtDNA content with type 2 diabetes (10, 11) . In our study, we could not detect a relation between mtDNA content in blood and prevalent type 2 diabetes in a case control setup. Post hoc power calculations showed that we had greater than 95% power to detect an effect comparable to the results of Lee et al. (10) (mtDNA content 35% lower in cases of type 2 diabetes) and 80% power to detect a difference of at least 10%. Therefore, we conclude that mtDNA content in blood is not associated with type 2 diabetes in our sample selection.
Incident type 2 diabetes and mtDNA content
To analyze the relation between mtDNA content and incident cases of type 2 diabetes, we analyzed two prospective studies, but we could not detect a consistent association with incident type 2 diabetes. A previous study had suggested a 25% decrease in converters (10) . We had greater than 95% power to detect a similar effect in both prospective 1 and prospective 2 (Botnia and Rotterdam) studies. This indicates that mtDNA content in blood is not a good predictor of future type 2 diabetes. Although the prospective 1 study shows a trend toward decreased risk for type 2 diabetes with increased mtDNA content, the prospective 2 study shows an opposite effect. This might be caused by the differences between the studies. For instance, participants from the prospective 1 sample are younger than those of the prospective 2 sample. Furthermore, there are more IGT and IFG subjects in the nonconverter group of the prospective 1 sample, compared with the prospective 2 sample. However, analyzing only NGT subjects does not change the outcome.
We conclude that mtDNA content in blood is not associated with incident type 2 diabetes, which argues against previous observations where low mtDNA content in blood was associated with type 2 diabetes, triglyceride storage, glucose homeostasis, insulin sensitivity, and insulin secretion (10, (12) (13) (14) (15) . A major difference between our and previous studies is the difference in ethnicity. All positive findings arose in Asian participants from Korea, whereas no associations were observed in Caucasians (10 -14) . Our data indicate that mtDNA content in blood is not useful as a predictor of type 2 diabetes in Caucasians. We cannot rule out any effects of mtDNA content in other tissues like muscle, pancreas, and adipose tissue on type 2 diabetes and related traits like insulin resistance and secretion. Muscle seems a highly relevant tissue to examine mitochondrial function because associations with mitochondrial activity and insulin resistance are observed (33, 34) , and it has already been reported that mtDNA content decreases with aging in muscle, but also in pancreas, liver, and blood (5, (35) (36) (37) . It seems that the decline in mtDNA content in muscle is faster than in blood. This may be related to the high level of oxidative metabolism in these tissues. Furthermore, it is speculated that the faster proliferative rate of hematopoietic stem cells provides them with the opportunity to remove damaged mtDNA and perhaps a better maintenance of mtDNA content (38, 39).
In our pooled dataset, we observed a negative correlation between mtDNA content and age that was male specific. To our knowledge, we are the first to show that the decline in mtDNA content might be male specific. The observed gender effect on mtDNA content, also observed by Xing et al. (6) , is probably caused by this gender-specific correlation between mtDNA content and aging. One might speculate that overall mitochondrial fitness is better retained in females, which might explain the observed dif-ference in life span between males and females. However, this hypothesis needs further investigation. The association between mtDNA content and BMI was very weak and was not observed by others (10 -15) . Therefore, it is likely that this is not a true association.
In summary, we have confirmed the heritability of mtDNA content, but could not find evidence for an association of mtDNA content in blood with prevalent or incident type 2 diabetes. The observed decline in mtDNA content in males might suggest enhanced mitochondrial fitness in elderly women. However, this needs further study in more suitable cohorts and experimental settings.
